Javascript must be enabled to continue!
Determination of Red Blood Cell Distribution Width in Patients with Primary Cutaneous Vasculitis Compared to Systemic Vasculitis
View through CrossRef
Introduction: Red blood cell distribution width (RDW) has been considered as an inflammatory marker in various disorders. Evaluation of RDW value can also be used as a novel and additional marker for differentiating systemic vasculitis from primary cutaneous vasculitis. Objective: To compare RDW value between patients with cutaneous vasculitis with systemic vasculitis, thereafter to find out it's role as an effective indicator to distinguish both forms of vasculitis.
Materials and Methods: This cross sectional observational study was conduct between from July 2016 to December 2017. Total of 48 patients were divided into primary cutaneous vasculitis and systemic vasculitis. Blood was collected in EDTA tube to measure RDW value. Patient’s disease activity also scored and plotted according to Birmingham vasculitis activity score. Statistical analysis was performed by using SPSS.
Results: Significantly high mean RDW were found in patients with systemic vasculitis compared to primary cutaneous vasculitis (15.09±0.92 vs. 13.48±1.1, p = 0.000). BVAS was significantly greater (13.93±5.10 vs. 4.87±2.69, p = < 0.001) in systemic vasculitis as well as in patients with high RDW group (11.73±5.71 vs. 5.37±3.96, p = < 0.001). Optimal RDW cut off point for differentiating systemic vasculitis from cutaneous vasculitis was 14.2 with 81.3% sensitivity and 81.2% specificity.
Conclusion: Present study revealed importance of RDW monitoring along with disease activity in patients with any form of vasculitis. Systemic vasculitis had higher level of RDW. So RDW can be considered as a marker to discriminate systemic vasculitis from primary cutaneous vasculitis.
Medicine Today 2021 Vol.33(2): 84-89
Bangladesh Journals Online (JOL)
Title: Determination of Red Blood Cell Distribution Width in Patients with Primary Cutaneous Vasculitis Compared to Systemic Vasculitis
Description:
Introduction: Red blood cell distribution width (RDW) has been considered as an inflammatory marker in various disorders.
Evaluation of RDW value can also be used as a novel and additional marker for differentiating systemic vasculitis from primary cutaneous vasculitis.
Objective: To compare RDW value between patients with cutaneous vasculitis with systemic vasculitis, thereafter to find out it's role as an effective indicator to distinguish both forms of vasculitis.
Materials and Methods: This cross sectional observational study was conduct between from July 2016 to December 2017.
Total of 48 patients were divided into primary cutaneous vasculitis and systemic vasculitis.
Blood was collected in EDTA tube to measure RDW value.
Patient’s disease activity also scored and plotted according to Birmingham vasculitis activity score.
Statistical analysis was performed by using SPSS.
Results: Significantly high mean RDW were found in patients with systemic vasculitis compared to primary cutaneous vasculitis (15.
09±0.
92 vs.
13.
48±1.
1, p = 0.
000).
BVAS was significantly greater (13.
93±5.
10 vs.
4.
87±2.
69, p = < 0.
001) in systemic vasculitis as well as in patients with high RDW group (11.
73±5.
71 vs.
5.
37±3.
96, p = < 0.
001).
Optimal RDW cut off point for differentiating systemic vasculitis from cutaneous vasculitis was 14.
2 with 81.
3% sensitivity and 81.
2% specificity.
Conclusion: Present study revealed importance of RDW monitoring along with disease activity in patients with any form of vasculitis.
Systemic vasculitis had higher level of RDW.
So RDW can be considered as a marker to discriminate systemic vasculitis from primary cutaneous vasculitis.
Medicine Today 2021 Vol.
33(2): 84-89.
Related Results
Determination of red blood cell distribution width in patients with primary cutaneous vasculitis compared to systemic vasculitis
Determination of red blood cell distribution width in patients with primary cutaneous vasculitis compared to systemic vasculitis
Background Red blood cell distribution width (RDW) has been considered as an inflammatory marker in various disorders. Evaluation of RDW value can also be used as a novel and addi...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
[RETRACTED] Guardian Blood Balance –Feel the difference Guardian Blood Balance makes! v1
[RETRACTED] Guardian Blood Balance –Feel the difference Guardian Blood Balance makes! v1
[RETRACTED]Guardian Blood Balance Reviews (Works Or Hoax) Does Guardian Botanicals Blood Balance AU Really Works? Read Updated Report! Diabetes and Hypertension is such a health p...
An update on the nomenclature for cutaneous vasculitis
An update on the nomenclature for cutaneous vasculitis
Purpose of review
Cutaneous vasculitis reflects a spectrum ranging from skin limited to severe systemic forms. To date, there is still no generally acknowledged nomencl...
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Blood Cross Matching Without Anti-Human Globulin (AHG) and Bovine Serum: A New Interest for an Old Idea
Blood Cross Matching Without Anti-Human Globulin (AHG) and Bovine Serum: A New Interest for an Old Idea
Abstract
Introduction
Transfusion medicine promotes the safety of blood transfusions by rigorously testing to eliminate risks of infection and hemolytic. The efficacy (to correct ...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
P184 Geographical variations in delivery of intravenous treatments for ANCA-associated vasculitis
P184 Geographical variations in delivery of intravenous treatments for ANCA-associated vasculitis
Abstract
Background/Aims
Timely access to intravenous immunosuppressant therapy is essential to effectively manage systemic vasc...

